BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10067244)

  • 1. [Association of the metabolic syndrome components in patients with arterial hypertension and their relationship with dyslipidemia].
    Oganov RG; Perova NV; Mamedov MN; Metel'skaia VA
    Ter Arkh; 1998; 70(12):19-23. PubMed ID: 10067244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
    Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
    Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of insulin resistance and hyperlipidemia in microvascular angina (syndrome X)].
    Langes K; Volk C; Schneider MA; Koschyk DH; Rinninger F; Nienaber CA
    Z Kardiol; 1995 Mar; 84(3):180-9. PubMed ID: 7732710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.
    Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J
    Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study.
    Han TS; Williams K; Sattar N; Hunt KJ; Lean ME; Haffner SM
    Obes Res; 2002 Sep; 10(9):923-31. PubMed ID: 12226141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of glucose, insulin, triglyceride, blood pressure, and oxidative stress after an oral glucose tolerance test in men with abdominal obesity.
    Nakatsuji H; Kishida K; Kitamura T; Nakajima C; Funahashi T; Shimomura I
    Metabolism; 2010 Apr; 59(4):520-6. PubMed ID: 19850310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects.
    Vidal J; Morínigo R; Codoceo VH; Casamitjana R; Pellitero S; Gomis R
    Int J Obes (Lond); 2005 Jun; 29(6):668-74. PubMed ID: 15753955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of obesity surgery on the metabolic syndrome.
    Lee WJ; Huang MT; Wang W; Lin CM; Chen TC; Lai IR
    Arch Surg; 2004 Oct; 139(10):1088-92. PubMed ID: 15492149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
    Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
    Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure.
    Hoffmann IS; Jimenez E; Cubeddu LX
    J Hum Hypertens; 2001 Jun; 15(6):407-12. PubMed ID: 11439316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC; Miranda WL; Chacra AR; Dib SA
    J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Qualitative and quantitiative differences in the plasma lipoproteins of obese, hyperlipidemic or normolipidemic men and women].
    Fernández V; Campos G; Rincón E; Valbuena H; Ryder E; Gomez ME; Raleigh X
    Invest Clin; 1996 Mar; 37(1):17-34. PubMed ID: 8920029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin.
    González AS; Guerrero DB; Soto MB; Díaz SP; Martinez-Olmos M; Vidal O
    Eur J Clin Nutr; 2006 Jun; 60(6):802-9. PubMed ID: 16493453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
    Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S
    Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between the prevalence of microalbuminuria and components of metabolic syndrome in Shanghai].
    Li Q; Jia WP; Lu JQ; Chen L; Wu YM; Jiang SY; Xiang KS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jan; 25(1):65-8. PubMed ID: 15061951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.